Vicodin as a brand-name product is essentially gone from pharmacy shelves, but the drug it contained, hydrocodone combined with acetaminophen, is still widely prescribed. It remains one of the most commonly dispensed opioid medications in the United States, though prescribing rates have dropped significantly over the past several years due to tighter regulations and a broader shift away from opioids for pain management.
What Happened to the Vicodin Brand
The name “Vicodin” became so well known that many people use it interchangeably with the generic drug. But the branded product has largely been replaced by generic versions of hydrocodone-acetaminophen, manufactured by companies like Amneal, Mallinckrodt, KVK-Tech, and others. These generics contain the same active ingredients at the same strengths and work identically. If your doctor prescribes hydrocodone-acetaminophen today, you’ll almost certainly receive a generic tablet.
Two Regulatory Changes That Reshaped Prescribing
Two major federal actions in quick succession made Vicodin and its generics harder to prescribe and safer to take.
The first was an FDA mandate issued in January 2011, requiring all prescription combination opioid-acetaminophen products to contain no more than 325 mg of acetaminophen per dose. Older Vicodin formulations contained up to 750 mg of acetaminophen per tablet, which created a real risk of liver damage, especially for patients taking multiple doses a day or using other acetaminophen-containing products (like Tylenol) at the same time. Manufacturers had until early 2014 to reformulate or pull their products. Research published by the National Institute of Diabetes and Digestive and Kidney Diseases later confirmed that this change led to a significant drop in hospitalizations and acute liver failure cases linked to opioid-acetaminophen combinations.
The second change came in October 2014, when the DEA reclassified all hydrocodone combination products from Schedule III to Schedule II. That single move had enormous practical consequences. Schedule II drugs cannot be called in to a pharmacy by phone, cannot have automatic refills, and require a new written or electronic prescription each time. Before this change, a doctor could phone in a Vicodin prescription and authorize five refills. Afterward, every fill required a new visit or at minimum a new prescription. This made hydrocodone significantly less convenient for both doctors and patients, and prescribing volumes dropped sharply.
How Much Prescribing Has Declined
The overall national opioid dispensing rate fell from 46.8 prescriptions per 100 people in 2019 to 35.4 per 100 people in 2024, according to the CDC. That figure includes all opioids, not just hydrocodone, but hydrocodone-acetaminophen has historically been one of the highest-volume opioids in the country, so it accounts for a meaningful share of that decline. The drop reflects a combination of stricter prescribing guidelines, increased awareness of addiction risks, and growing use of non-opioid alternatives.
When Doctors Still Prescribe It
Hydrocodone-acetaminophen is indicated for moderate to moderately severe pain. In practice, that means it still gets prescribed after surgical procedures, dental extractions, fractures, and other situations where over-the-counter pain relievers aren’t enough but stronger opioids like oxycodone or morphine aren’t warranted. It also still appears in some chronic pain management plans, though guidelines now strongly discourage opioids as a first-line treatment for ongoing pain.
Current formulations come in tablets with 2.5, 5, 7.5, or 10 mg of hydrocodone, all paired with 300 or 325 mg of acetaminophen. A liquid solution is also available for patients who can’t swallow tablets. Prescriptions today are typically written for shorter durations than they were a decade ago, often just three to seven days for acute pain.
What Gets Prescribed Instead
The CDC now recommends that clinicians maximize non-opioid options before reaching for hydrocodone or any other opioid. For acute pain, that usually means anti-inflammatory drugs like ibuprofen or naproxen, plain acetaminophen, or topical pain relievers. These carry far lower risks of dependence and, for many types of pain, work just as well.
For chronic pain, the alternatives are broader. Certain antidepressants that also dampen pain signals are commonly used, along with anticonvulsant medications originally developed for seizures but effective against nerve pain. Topical options like lidocaine patches and capsaicin cream can help with localized pain. Physical therapy, exercise programs, cognitive behavioral therapy, acupuncture, and massage all have evidence supporting their use for ongoing pain and are increasingly part of standard treatment plans.
When an opioid is genuinely needed, hydrocodone-acetaminophen is still a reasonable option. It hasn’t been pulled from the market or banned. But the threshold for prescribing it is much higher than it was 10 or 15 years ago, and patients receiving it can expect closer monitoring, shorter prescription durations, and a conversation about risks that earlier generations of patients rarely had.